Trial Outcomes & Findings for Intraoperative Methadone vs Morphine for Postoperative Pain Control in Patients Undergoing Surgery of the Tibia (NCT NCT01430182)

NCT ID: NCT01430182

Last Updated: 2016-04-04

Results Overview

Number of morphine equivalents used by subject during first 24 hours after discharge from Post-Anesthesia Care Unit

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

17 participants

Primary outcome timeframe

First 24 hours after discharge from Post-Anesthesia Care Unit

Results posted on

2016-04-04

Participant Flow

Subjects were inpatients in Ben Taub General Hospital, a General and Teaching Hospital in Houston, Texas. Subjects were enrolled from October 2011 through May 2013.

18 subjects were approached for participation. 1 was a screen failure, yielding 17 subjects who were randomized and received methadone or morphine

Participant milestones

Participant milestones
Measure
Methadone 0.2 mg/kg
0.2 mg/kg methadone by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Methadone: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
Morphine 0.2 mg/kg
0.2 mg/kg morphine by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Morphine: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
Overall Study
STARTED
9
8
Overall Study
COMPLETED
9
8
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Intraoperative Methadone vs Morphine for Postoperative Pain Control in Patients Undergoing Surgery of the Tibia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Methadone 0.2 mg/kg
n=9 Participants
0.2 mg/kg methadone by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Methadone: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
Morphine 0.2 mg/kg
n=8 Participants
0.2 mg/kg morphine by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Morphine: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
Total
n=17 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=39 Participants
0 Participants
n=41 Participants
0 Participants
n=35 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=39 Participants
8 Participants
n=41 Participants
17 Participants
n=35 Participants
Age, Categorical
>=65 years
0 Participants
n=39 Participants
0 Participants
n=41 Participants
0 Participants
n=35 Participants
Age, Continuous
31.9 years
STANDARD_DEVIATION 7.4 • n=39 Participants
29.3 years
STANDARD_DEVIATION 10.2 • n=41 Participants
30.7 years
STANDARD_DEVIATION 8.6 • n=35 Participants
Sex: Female, Male
Female
2 Participants
n=39 Participants
1 Participants
n=41 Participants
3 Participants
n=35 Participants
Sex: Female, Male
Male
7 Participants
n=39 Participants
7 Participants
n=41 Participants
14 Participants
n=35 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
7 Participants
n=39 Participants
4 Participants
n=41 Participants
11 Participants
n=35 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
2 Participants
n=39 Participants
4 Participants
n=41 Participants
6 Participants
n=35 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=39 Participants
0 Participants
n=41 Participants
0 Participants
n=35 Participants
Region of Enrollment
United States
9 participants
n=39 Participants
8 participants
n=41 Participants
17 participants
n=35 Participants

PRIMARY outcome

Timeframe: First 24 hours after discharge from Post-Anesthesia Care Unit

Number of morphine equivalents used by subject during first 24 hours after discharge from Post-Anesthesia Care Unit

Outcome measures

Outcome measures
Measure
Methadone 0.2 mg/kg
n=9 Participants
0.2 mg/kg methadone by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Methadone: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
Morphine 0.2 mg/kg
n=8 Participants
0.2 mg/kg morphine by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Morphine: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
Opioid Consumption
50.9 mg of morphine IV equivalents
Standard Deviation 38.7
37.5 mg of morphine IV equivalents
Standard Deviation 15.4

Adverse Events

Methadone 0.2 mg/kg

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Morphine 0.2 mg/kg

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Methadone 0.2 mg/kg
n=9 participants at risk
0.2 mg/kg methadone by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Methadone: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
Morphine 0.2 mg/kg
n=8 participants at risk
0.2 mg/kg morphine by actual body weight, administered over ten minutes, initiated after induction of anesthesia and endotracheal intubation complete. Morphine: 0.2 mg\*kg-1 by actual body weight, administered over 10 minutes, once induction of anesthesia and endotracheal intubation are complete.
General disorders
Excessive sedation or excessive somnolence
11.1%
1/9 • Number of events 1
0.00%
0/8

Additional Information

Neil Bailard

Baylor College of Medicine

Phone: 713-798-7356

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place